These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Massachusetts | 04-2348234 | |
(State or other jurisdiction of | (I.R.S. Employer | |
incorporation or organization) | Identification No.) | |
One Technology Way, Norwood, MA | 02062-9106 | |
(Address of principal executive offices) | (Zip Code) |
Large accelerated filer þ | Accelerated filer o | Non-accelerated filer o | Smaller reporting company o | |||
(Do not check if a smaller reporting company) |
Three Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Revenue
|
$ | 720,290 | $ | 491,991 | ||||
Cost of sales (1)
|
240,088 | 225,762 | ||||||
|
||||||||
Gross margin
|
480,202 | 266,229 | ||||||
Operating expenses:
|
||||||||
Research and development (1)
|
126,987 | 107,578 | ||||||
Selling, marketing, general and administrative (1)
|
102,070 | 79,706 | ||||||
|
||||||||
|
229,057 | 187,284 | ||||||
|
||||||||
Operating income
|
251,145 | 78,945 | ||||||
Nonoperating (income) expense:
|
||||||||
Interest expense
|
2,614 | 1,368 | ||||||
Interest income
|
(3,206 | ) | (2,558 | ) | ||||
Other, net
|
416 | 108 | ||||||
|
||||||||
|
(176 | ) | (1,082 | ) | ||||
|
||||||||
|
||||||||
Income before income taxes
|
251,321 | 80,027 | ||||||
|
||||||||
Provision for income taxes
|
51,830 | 14,567 | ||||||
|
||||||||
|
||||||||
Net income
|
$ | 199,491 | $ | 65,460 | ||||
|
||||||||
|
||||||||
Shares used to compute earnings per share — basic
|
298,027 | 291,387 | ||||||
|
||||||||
Shares used to compute earnings per share — diluted
|
306,168 | 293,084 | ||||||
|
||||||||
|
||||||||
Basic earnings per share
|
$ | 0.67 | $ | 0.22 | ||||
|
||||||||
|
||||||||
Diluted earnings per share
|
$ | 0.65 | $ | 0.22 | ||||
|
||||||||
|
||||||||
Dividends declared and paid per share
|
$ | 0.22 | $ | 0.20 | ||||
|
||||||||
|
||||||||
(1) Includes stock-based compensation expense as follows:
|
||||||||
Cost of sales
|
$ | 1,878 | $ | 1,942 | ||||
Research and development
|
$ | 5,996 | $ | 5,508 | ||||
Selling, marketing, general and administrative
|
$ | 5,302 | $ | 4,565 |
1
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Revenue
|
$ | 1,991,513 | $ | 1,443,308 | ||||
Cost of sales (1)
|
708,320 | 646,525 | ||||||
|
||||||||
Gross margin
|
1,283,193 | 796,783 | ||||||
Operating expenses:
|
||||||||
Research and development (1)
|
364,165 | 336,854 | ||||||
Selling, marketing, general and administrative (1)
|
288,211 | 249,828 | ||||||
Special charges
|
16,483 | 53,656 | ||||||
|
||||||||
|
668,859 | 640,338 | ||||||
|
||||||||
Operating income
|
614,334 | 156,445 | ||||||
Nonoperating (income) expense:
|
||||||||
Interest expense
|
7,720 | 1,368 | ||||||
Interest income
|
(7,411 | ) | (13,881 | ) | ||||
Other, net
|
417 | (1,260 | ) | |||||
|
||||||||
|
726 | (13,773 | ) | |||||
|
||||||||
|
||||||||
Income from continuing operations before income taxes
|
613,608 | 170,218 | ||||||
|
||||||||
Provision for income taxes
|
127,377 | 28,419 | ||||||
|
||||||||
|
||||||||
Income from continuing operations, net of tax
|
486,231 | 141,799 | ||||||
|
||||||||
|
||||||||
Discontinued operations:
|
||||||||
Income from discontinued operations, net of tax
|
— | 364 | ||||||
Gain on sale of discontinued operations, net of tax
|
859 | — | ||||||
|
||||||||
Total income from discontinued operations, net of tax
|
859 | 364 | ||||||
|
||||||||
Net income
|
$ | 487,090 | $ | 142,163 | ||||
|
||||||||
|
||||||||
Shares used to compute earnings per share — basic
|
297,107 | 291,267 | ||||||
|
||||||||
Shares used to compute earnings per share — diluted
|
305,578 | 292,259 | ||||||
|
||||||||
|
||||||||
Basic earnings per share from continuing operations
|
$ | 1.64 | $ | 0.49 | ||||
|
||||||||
Basic earnings per share
|
$ | 1.64 | $ | 0.49 | ||||
|
||||||||
|
||||||||
Diluted earnings per share from continuing operations
|
$ | 1.59 | $ | 0.49 | ||||
|
||||||||
Diluted earnings per share
|
$ | 1.59 | $ | 0.49 | ||||
|
||||||||
|
||||||||
Dividends declared and paid per share
|
$ | 0.62 | $ | 0.60 | ||||
|
||||||||
|
||||||||
(1) Includes stock-based compensation expense as follows:
|
||||||||
Cost of sales
|
$ | 5,409 | $ | 5,334 | ||||
Research and development
|
$ | 17,323 | $ | 16,880 | ||||
Selling, marketing, general and administrative
|
$ | 15,534 | $ | 13,778 |
2
July 31, 2010 | October 31, 2009 | |||||||
Assets
|
||||||||
|
||||||||
Cash and cash equivalents
|
$ | 993,429 | $ | 639,729 | ||||
Short-term investments
|
1,514,886 | 1,176,244 | ||||||
Accounts receivable, net
|
357,479 | 301,036 | ||||||
Inventory (1):
|
||||||||
Raw materials
|
17,366 | 13,373 | ||||||
Work in process
|
168,065 | 173,696 | ||||||
Finished goods
|
79,835 | 66,092 | ||||||
|
||||||||
|
265,266 | 253,161 | ||||||
Deferred tax assets
|
70,782 | 78,740 | ||||||
Deferred compensation plan investments
|
— | 1,363 | ||||||
Prepaid expenses and other current assets
|
32,696 | 40,363 | ||||||
|
||||||||
Total current assets
|
3,234,538 | 2,490,636 | ||||||
|
||||||||
|
||||||||
Property, plant and equipment, at cost:
|
||||||||
Land and buildings
|
400,856 | 395,151 | ||||||
Machinery and equipment
|
1,549,064 | 1,511,822 | ||||||
Office equipment
|
56,152 | 56,294 | ||||||
Leasehold improvements
|
67,716 | 66,847 | ||||||
|
||||||||
|
2,073,788 | 2,030,114 | ||||||
Less accumulated depreciation and amortization
|
1,610,037 | 1,553,598 | ||||||
|
||||||||
Net property, plant and equipment
|
463,751 | 476,516 | ||||||
|
||||||||
Deferred compensation plan investments
|
7,998 | 6,580 | ||||||
Other investments
|
1,140 | 1,485 | ||||||
Goodwill
|
250,834 | 250,881 | ||||||
Intangible assets, net
|
1,891 | 6,855 | ||||||
Deferred tax assets
|
83,268 | 73,646 | ||||||
Other assets
|
60,648 | 35,658 | ||||||
Non-current assets of discontinued operations
|
— | 62,037 | ||||||
|
||||||||
Total other assets
|
405,779 | 437,142 | ||||||
|
||||||||
|
$ | 4,104,068 | $ | 3,404,294 | ||||
|
(1) | Includes $2,492 and $2,718 related to stock-based compensation at July 31, 2010 and October 31, 2009, respectively. |
3
July 31, 2010 | October 31, 2009 | |||||||
Liabilities and Shareholders’ Equity
|
||||||||
|
||||||||
Accounts payable
|
$ | 129,967 | $ | 107,334 | ||||
Deferred income on shipments to distributors, net
|
214,727 | 149,278 | ||||||
Income taxes payable
|
84,017 | 6,445 | ||||||
Deferred compensation plan liability
|
— | 1,363 | ||||||
Accrued liabilities
|
159,668 | 122,193 | ||||||
|
||||||||
Total current liabilities
|
588,379 | 386,613 | ||||||
|
||||||||
|
||||||||
Long-term debt
|
395,756 | 379,626 | ||||||
Deferred income taxes
|
28,749 | 36,232 | ||||||
Deferred compensation plan liability
|
7,998 | 6,577 | ||||||
Other non-current liabilities
|
48,711 | 66,097 | ||||||
|
||||||||
Total non-current liabilities
|
481,214 | 488,532 | ||||||
|
||||||||
|
||||||||
Commitments and contingencies
|
||||||||
|
||||||||
Shareholders’ Equity
|
||||||||
|
||||||||
Preferred stock, $1.00 par value, 471,934 shares authorized,
none outstanding
|
— | — | ||||||
Common stock, $0.16 2/3 par value, 1,200,000,000 shares
authorized, 298,089,485 shares issued and outstanding
(291,861,767 on October 31, 2009)
|
49,683 | 48,645 | ||||||
Capital in excess of par value
|
265,558 | 56,306 | ||||||
Retained earnings
|
2,737,161 | 2,434,446 | ||||||
Accumulated other comprehensive loss
|
(17,927 | ) | (10,248 | ) | ||||
|
||||||||
Total shareholders’ equity
|
3,034,475 | 2,529,149 | ||||||
|
||||||||
|
$ | 4,104,068 | $ | 3,404,294 | ||||
|
4
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Cash flows from operating activities:
|
||||||||
|
||||||||
Net income
|
$ | 487,090 | $ | 142,163 | ||||
Adjustments to reconcile net income
to net cash provided by operations:
|
||||||||
Depreciation
|
86,776 | 102,495 | ||||||
Amortization of intangibles
|
4,189 | 5,227 | ||||||
Stock-based compensation expense
|
38,266 | 35,992 | ||||||
Gain on sale of business
|
(859 | ) | — | |||||
Income tax payments related to gain on sale of businesses
|
— | (4,105 | ) | |||||
Excess tax benefit-stock options
|
(153 | ) | (5 | ) | ||||
Deferred income taxes
|
(16,233 | ) | (221 | ) | ||||
Non-cash portion of special charge
|
487 | 13,768 | ||||||
Other non-cash activity
|
1,420 | 1,299 | ||||||
Changes in operating assets and liabilities
|
115,916 | (27,143 | ) | |||||
|
||||||||
Total adjustments
|
229,809 | 127,307 | ||||||
|
||||||||
Net cash provided by operating activities
|
716,899 | 269,470 | ||||||
|
||||||||
|
||||||||
Cash flows from investing activities:
|
||||||||
Purchases of short-term available-for-sale investments
|
(2,354,565 | ) | (1,914,428 | ) | ||||
Maturities of short-term available-for-sale investments
|
2,015,706 | 1,535,941 | ||||||
Net proceeds (expenditures) from sale of business
|
63,036 | (1,340 | ) | |||||
Additions to property, plant and equipment
|
(73,794 | ) | (39,706 | ) | ||||
Payments for acquisitions
|
— | (8,360 | ) | |||||
Decrease (increase) in other assets
|
3,668 | (5,750 | ) | |||||
|
||||||||
Net cash used for investing activities
|
(345,949 | ) | (433,643 | ) | ||||
|
||||||||
|
||||||||
Cash flows from financing activities:
|
||||||||
Proceeds from issuance of long-term debt
|
— | 370,350 | ||||||
Dividend payments to shareholders
|
(184,375 | ) | (174,662 | ) | ||||
Repurchase of common stock
|
(4,047 | ) | (3,762 | ) | ||||
Net proceeds from employee stock plans
|
174,002 | 8,740 | ||||||
Other financing activities
|
502 | — | ||||||
Excess tax benefit-stock options
|
153 | 5 | ||||||
|
||||||||
Net cash (used for) provided by activities
|
(13,765 | ) | 200,671 | |||||
|
||||||||
Effect of exchange rate changes on cash
|
(3,485 | ) | 2,618 | |||||
|
||||||||
|
||||||||
Net increase in cash and cash equivalents
|
353,700 | 39,116 | ||||||
Cash and cash equivalents at beginning of period
|
639,729 | 593,599 | ||||||
|
||||||||
Cash and cash equivalents at end of period
|
$ | 993,429 | $ | 632,715 | ||||
|
5
6
Three Months Ended | Nine Months Ended | |||||||||||||||
Stock Options | July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | ||||||||||||
Options granted (in thousands)
|
12 | 35 | 1,850 | 5,650 | ||||||||||||
Weighted-average exercise price per share
|
$ | 29.19 | $ | 22.96 | $ | 31.51 | $ | 19.60 | ||||||||
Weighted-average grant-date fair value per share
|
$ | 7.00 | $ | 6.26 | $ | 7.78 | $ | 7.42 | ||||||||
Assumptions:
|
||||||||||||||||
Weighted-average expected volatility
|
33.3 | % | 39.2 | % | 31.4 | % | 58.9 | % | ||||||||
Weighted-average expected term (in years)
|
5.3 | 5.3 | 5.3 | 5.3 | ||||||||||||
Risk-free interest rate
|
2.1 | % | 2.4 | % | 2.6 | % | 1.7 | % | ||||||||
Expected dividend yield
|
3.0 | % | 3.5 | % | 2.5 | % | 4.1 | % |
7
Weighted- | ||||||||||||||||
Average | ||||||||||||||||
Options | Weighted- | Remaining | Aggregate | |||||||||||||
Outstanding | Average Exercise | Contractual | Intrinsic | |||||||||||||
Activity during the Three Months Ended July 31, 2010 | (in thousands) | Price Per Share | Term in Years | Value | ||||||||||||
Options outstanding at May 1, 2010
|
45,686 | $ | 29.77 | |||||||||||||
Options granted
|
12 | $ | 29.19 | |||||||||||||
Options exercised
|
(235 | ) | $ | 20.70 | ||||||||||||
Options forfeited
|
(314 | ) | $ | 27.25 | ||||||||||||
Options expired
|
(190 | ) | $ | 55.01 | ||||||||||||
|
||||||||||||||||
Options outstanding at July 31, 2010
|
44,959 | $ | 29.73 | 4.8 | $ | 129,736 | ||||||||||
|
||||||||||||||||
Options exercisable at July 31, 2010
|
19,815 | $ | 32.71 | 3.7 | $ | 60,991 | ||||||||||
|
||||||||||||||||
Options vested or expected to vest at July 31, 2010 (1)
|
43,606 | $ | 29.81 | 4.7 | $ | 125,245 | ||||||||||
|
(1) | In addition to the vested options, the Company expects a portion of the unvested options to vest at some point in the future. Options expected to vest is calculated by applying an estimated forfeiture rate to the unvested options. |
Weighted- Average | ||||||||
Exercise Price Per | ||||||||
Activity during the Nine Months Ended July 31, 2010 | Options Outstanding | Share | ||||||
Options outstanding at October 31, 2009
|
52,463 | $ | 29.71 | |||||
Options granted
|
1,850 | $ | 31.51 | |||||
Options exercised
|
(7,121 | ) | $ | 27.83 | ||||
Options forfeited
|
(993 | ) | $ | 27.60 | ||||
Options expired
|
(1,240 | ) | $ | 44.42 | ||||
|
||||||||
Options outstanding at July 31, 2010
|
44,959 | $ | 29.73 | |||||
|
8
Restricted | Weighted- | |||||||
Stock Units | Average Grant | |||||||
Outstanding | Date Fair Value | |||||||
Activity during the Three Months Ended July 31, 2010 | (in thousands) | Per Share | ||||||
Restricted stock units outstanding at May 1, 2010
|
1,264 | $ | 28.23 | |||||
Units granted
|
9 | $ | 27.58 | |||||
Restrictions lapsed
|
(2 | ) | $ | 33.65 | ||||
Forfeited
|
(10 | ) | $ | 29.13 | ||||
|
||||||||
Restricted stock units outstanding at July 31, 2010
|
1,261 | $ | 28.22 | |||||
|
Restricted | Weighted- | |||||||
Stock Units | Average Grant | |||||||
Outstanding | Date Fair Value | |||||||
Activity during the Nine Months Ended July 31, 2010 | (in thousands) | Per Share | ||||||
Restricted stock units outstanding at October 31, 2009
|
135 | $ | 22.19 | |||||
Units granted
|
1,156 | $ | 28.89 | |||||
Restrictions lapsed
|
(14 | ) | $ | 24.61 | ||||
Forfeited
|
(16 | ) | $ | 29.29 | ||||
|
||||||||
Restricted stock units outstanding at July 31, 2010
|
1,261 | $ | 28.22 | |||||
|
9
Three Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Net income
|
$ | 199,491 | $ | 65,460 | ||||
|
||||||||
Foreign currency translation adjustments
|
(4,772 | ) | 5,629 | |||||
Change in unrealized holding losses (net of taxes of $10 and
$2, respectively) on securities classified as short-term investments
|
(69 | ) | (12 | ) | ||||
|
||||||||
Change in unrealized holding gains (net of taxes of $53
and $211, respectively) on securities classified as other investments
|
98 | 391 | ||||||
|
||||||||
Change in unrealized gains (net of taxes of $312 and $1,336,
respectively) on derivative instruments designated as cash flow hedges
|
1,588 | 8,013 | ||||||
|
||||||||
Pension plans
|
||||||||
Transition asset (obligation)
|
4 | (19 | ) | |||||
Net actuarial loss
|
(60 | ) | (643 | ) | ||||
|
||||||||
Other comprehensive (loss) income
|
(3,211 | ) | 13,359 | |||||
|
||||||||
Comprehensive income
|
$ | 196,280 | $ | 78,819 | ||||
|
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Income from continuing operations, net of tax
|
$ | 486,231 | $ | 141,799 | ||||
|
||||||||
Foreign currency translation adjustments
|
(1,091 | ) | 9,803 | |||||
|
||||||||
Change in unrealized holding losses (net of taxes of $26 and
$352, respectively) on securities classified as short-term investments
|
(191 | ) | (2,493 | ) | ||||
|
||||||||
Change in unrealized holding gains (net of taxes of $107
and $265, respectively) on securities classified as other investments
|
198 | 491 | ||||||
|
||||||||
Change in unrealized (losses) gains (net of taxes of $1,053 and $3,837,
respectively) on derivative instruments designated as cash flow hedges
|
(7,178 | ) | 25,140 | |||||
|
||||||||
Pension plans
|
||||||||
Prior service cost
|
(1 | ) | 1 | |||||
Transition asset (obligation)
|
5 | (27 | ) | |||||
Net actuarial gain (loss)
|
579 | (1,544 | ) | |||||
|
||||||||
Other comprehensive (loss) income
|
(7,679 | ) | 31,371 | |||||
|
||||||||
Comprehensive income from
continuing operations
|
478,552 | 173,170 | ||||||
|
||||||||
Income from discontinued operations, net of tax
|
859 | 364 | ||||||
|
||||||||
Comprehensive income
|
$ | 479,411 | $ | 173,534 | ||||
|
10
July 31, 2010 | October 31, 2009 | |||||||
Foreign currency translation adjustment
|
$ | (8,567 | ) | $ | (7,476 | ) | ||
Unrealized gains on available-for-sale securities
|
621 | 932 | ||||||
Unrealized losses on available-for-sale securities
|
(258 | ) | (576 | ) | ||||
Unrealized (losses) gains on derivative instruments
|
(1,569 | ) | 5,609 | |||||
Pension plans
|
||||||||
Prior service cost
|
(1 | ) | — | |||||
Transition obligation
|
(44 | ) | (49 | ) | ||||
Net actuarial loss
|
(8,109 | ) | (8,688 | ) | ||||
|
||||||||
Total accumulated other comprehensive loss
|
$ | (17,927 | ) | $ | (10,248 | ) | ||
|
Three Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Basic:
|
||||||||
Net income
|
$ | 199,491 | $ | 65,460 | ||||
|
||||||||
Weighted-average shares outstanding
|
298,027 | 291,387 | ||||||
|
||||||||
|
||||||||
Earnings per share:
|
$ | 0.67 | $ | 0.22 | ||||
|
||||||||
|
||||||||
Diluted:
|
||||||||
Net income
|
$ | 199,491 | $ | 65,460 | ||||
|
||||||||
|
||||||||
Weighted-average shares outstanding
|
298,027 | 291,387 | ||||||
Assumed exercise of common stock equivalents
|
8,141 | 1,697 | ||||||
|
||||||||
Weighted-average common and common equivalent shares
|
306,168 | 293,084 | ||||||
|
||||||||
|
||||||||
Earnings per share:
|
$ | 0.65 | $ | 0.22 | ||||
|
||||||||
|
||||||||
Anti-dilutive common stock equivalents related to outstanding stock options
|
19,464 | 60,279 |
11
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Income from continuing operations, net of tax
|
$ | 486,231 | $ | 141,799 | ||||
Total income from discontinued operations, net of tax
|
859 | 364 | ||||||
|
||||||||
Net income
|
$ | 487,090 | $ | 142,163 | ||||
|
||||||||
|
||||||||
Basic shares:
|
||||||||
Weighted-average shares outstanding
|
297,107 | 291,267 | ||||||
|
||||||||
|
||||||||
Earnings per share-basic:
|
||||||||
Income from continuing operations, net of tax
|
$ | 1.64 | $ | 0.49 | ||||
Total income from discontinued operations, net of tax
|
0.00 | 0.00 | ||||||
|
||||||||
Net income
|
$ | 1.64 | $ | 0.49 | ||||
|
||||||||
|
||||||||
Diluted shares:
|
||||||||
Weighted-average shares outstanding
|
297,107 | 291,267 | ||||||
Assumed exercise of common stock equivalents
|
8,471 | 992 | ||||||
|
||||||||
Weighted-average common and common equivalent shares
|
305,578 | 292,259 | ||||||
|
||||||||
|
||||||||
Earnings per share-diluted:
|
||||||||
Income from continuing operations, net of tax
|
$ | 1.59 | $ | 0.49 | ||||
Total income from discontinued operations, net of tax
|
0.00 | 0.00 | ||||||
|
||||||||
Net income
|
$ | 1.59 | $ | 0.49 | ||||
|
||||||||
|
||||||||
Anti-dilutive common stock equivalents related to outstanding stock options
|
19,449 | 63,967 |
12
Consolidation | Closure of | |||||||||||||||||||
Closure of Wafer | of a Wafer | Reduction | Wafer | |||||||||||||||||
Fabrication | Fabrication | of | Fabrication | |||||||||||||||||
Facility | Facility in | Operating | Facility | Total Special | ||||||||||||||||
Income Statement | in Sunnyvale | Limerick | Costs | in Cambridge | Charges | |||||||||||||||
Fiscal 2005 Charges:
|
||||||||||||||||||||
Workforce reductions
|
$ | 20,315 | $ | — | $ | — | $ | — | $ | 20,315 | ||||||||||
|
||||||||||||||||||||
Total Fiscal 2005 Charges
|
$ | 20,315 | $ | — | $ | — | $ | — | $ | 20,315 | ||||||||||
|
||||||||||||||||||||
Fiscal 2006 Charges:
|
||||||||||||||||||||
Change in estimate
|
(2,029 | ) | — | — | — | (2,029 | ) | |||||||||||||
|
||||||||||||||||||||
Total Fiscal 2006 Charges
|
$ | (2,029 | ) | $ | — | $ | — | $ | — | $ | (2,029 | ) | ||||||||
|
||||||||||||||||||||
Fiscal 2007 Charges:
|
||||||||||||||||||||
Facility closure costs
|
10,288 | — | — | — | 10,288 | |||||||||||||||
Workforce reductions
|
— | 13,748 | — | — | 13,748 | |||||||||||||||
|
||||||||||||||||||||
Total Fiscal 2007 Charges
|
$ | 10,288 | $ | 13,748 | $ | — | $ | — | $ | 24,036 | ||||||||||
|
||||||||||||||||||||
Fiscal 2008 Charges:
|
||||||||||||||||||||
Workforce reductions
|
— | — | 1,627 | — | 1,627 | |||||||||||||||
Change in estimate
|
— | 1,461 | — | — | 1,461 | |||||||||||||||
|
||||||||||||||||||||
Total Fiscal 2008 Charges
|
$ | — | $ | 1,461 | $ | 1,627 | $ | — | $ | 3,088 | ||||||||||
|
||||||||||||||||||||
Fiscal 2009 Charges:
|
||||||||||||||||||||
Workforce reductions
|
— | — | 26,583 | 7,446 | 34,029 | |||||||||||||||
Facility closure costs
|
— | 1,191 | 2,411 | 57 | 3,659 | |||||||||||||||
Non-cash impairment charge
|
— | — | 839 | 14,629 | 15,468 | |||||||||||||||
Other items
|
— | — | 500 | — | 500 | |||||||||||||||
|
||||||||||||||||||||
Total Fiscal 2009 Charges
|
$ | — | $ | 1,191 | $ | 30,333 | $ | 22,132 | $ | 53,656 | ||||||||||
|
||||||||||||||||||||
Fiscal 2010 Charges:
|
||||||||||||||||||||
|
||||||||||||||||||||
Workforce reductions
|
— | — | 10,908 | — | 10,908 | |||||||||||||||
Facility closure costs
|
375 | — | — | 4,689 | 5,064 | |||||||||||||||
Non-cash impairment charge
|
— | — | 487 | — | 487 | |||||||||||||||
Other items
|
— | — | 24 | — | 24 | |||||||||||||||
|
||||||||||||||||||||
Total Fiscal 2010 Charges
|
$ | 375 | $ | — | $ | 11,419 | $ | 4,689 | $ | 16,483 | ||||||||||
|
13
Consolidation | Closure of | |||||||||||||||||||
of a Wafer | Wafer | |||||||||||||||||||
Closure of Wafer | Fabrication | Reduction of | Fabrication | |||||||||||||||||
Fabrication Facility | Facility in | Operating | Facility | Total Special | ||||||||||||||||
Balance Sheet | in Sunnyvale | Limerick | Costs | in Cambridge | Charges | |||||||||||||||
Balance at October 31, 2009
|
$ | 169 | $ | 312 | $ | 8,161 | $ | 6,690 | $ | 15,332 | ||||||||||
|
||||||||||||||||||||
Fiscal 2010 special charges
|
375 | — | 11,419 | 4,689 | 16,483 | |||||||||||||||
Severance payments
|
— | (155 | ) | (2,464 | ) | (3,029 | ) | (5,648 | ) | |||||||||||
Facility closure costs
|
(169 | ) | — | (261 | ) | (2,025 | ) | (2,455 | ) | |||||||||||
Non-cash impairment charge
|
— | — | (487 | ) | — | (487 | ) | |||||||||||||
Effect of foreign currency on accrual
|
— | (10 | ) | (65 | ) | — | (75 | ) | ||||||||||||
|
||||||||||||||||||||
Balance at January 30, 2010
|
$ | 375 | $ | 147 | $ | 16,303 | $ | 6,325 | $ | 23,150 | ||||||||||
|
||||||||||||||||||||
Severance payments
|
— | (147 | ) | (4,890 | ) | (1,140 | ) | (6,177 | ) | |||||||||||
Facility closure costs
|
(375 | ) | — | (184 | ) | (674 | ) | (1,233 | ) | |||||||||||
Other payments
|
— | — | (24 | ) | — | (24 | ) | |||||||||||||
Effect of foreign currency on accrual
|
— | — | (72 | ) | — | (72 | ) | |||||||||||||
|
||||||||||||||||||||
Balance at May 1, 2010
|
$ | — | $ | — | $ | 11,133 | $ | 4,511 | $ | 15,644 | ||||||||||
|
||||||||||||||||||||
Severance payments
|
— | — | (2,935 | ) | (631 | ) | (3,566 | ) | ||||||||||||
Facility closure costs
|
— | — | (220 | ) | (673 | ) | (893 | ) | ||||||||||||
Effect of foreign currency on accrual
|
— | — | (39 | ) | — | (39 | ) | |||||||||||||
|
||||||||||||||||||||
Balance at July 31, 2010
|
$ | — | $ | — | $ | 7,939 | $ | 3,207 | $ | 11,146 | ||||||||||
|
14
15
Three Months Ended | Three Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue | Y/Y% | Revenue | Revenue* | ||||||||||||||||
Industrial
|
$ | 340,505 | 47 | % | 69 | % | $ | 201,900 | 41 | % | ||||||||||
Automotive
|
83,539 | 12 | % | 62 | % | 51,497 | 10 | % | ||||||||||||
Consumer
|
128,616 | 18 | % | 23 | % | 104,432 | 21 | % | ||||||||||||
Communications
|
153,657 | 21 | % | 24 | % | 123,550 | 25 | % | ||||||||||||
Computer
|
13,973 | 2 | % | 32 | % | 10,612 | 2 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 720,290 | 100 | % | 46 | % | $ | 491,991 | 100 | % | ||||||||||
|
* | The sum of the individual percentages does not equal the total due to rounding. |
Nine Months Ended | Nine Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue* | Y/Y% | Revenue | Revenue | ||||||||||||||||
Industrial
|
$ | 918,419 | 46 | % | 46 | % | $ | 629,676 | 44 | % | ||||||||||
Automotive
|
239,943 | 12 | % | 82 | % | 131,510 | 9 | % | ||||||||||||
Consumer
|
366,546 | 18 | % | 40 | % | 262,576 | 18 | % | ||||||||||||
Communications
|
425,496 | 21 | % | 11 | % | 383,713 | 27 | % | ||||||||||||
Computer
|
41,109 | 2 | % | 15 | % | 35,833 | 2 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 1,991,513 | 100 | % | 38 | % | $ | 1,443,308 | 100 | % | ||||||||||
|
* | The sum of the individual percentages does not equal the total due to rounding. |
Three Months Ended | Three Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue* | Y/Y% | Revenue | Revenue | ||||||||||||||||
Converters
|
$ | 334,288 | 46 | % | 34 | % | $ | 249,162 | 51 | % | ||||||||||
Amplifiers / Radio frequency
|
184,397 | 26 | % | 53 | % | 120,288 | 24 | % | ||||||||||||
Other analog
|
87,651 | 12 | % | 60 | % | 54,757 | 11 | % | ||||||||||||
|
||||||||||||||||||||
Subtotal analog signal processing
|
606,336 | 84 | % | 43 | % | 424,207 | 86 | % | ||||||||||||
Power management & reference
|
53,413 | 7 | % | 91 | % | 27,987 | 6 | % | ||||||||||||
|
||||||||||||||||||||
Total analog products
|
$ | 659,749 | 92 | % | 46 | % | $ | 452,194 | 92 | % | ||||||||||
|
||||||||||||||||||||
Digital signal processing
|
60,541 | 8 | % | 52 | % | 39,797 | 8 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 720,290 | 100 | % | 46 | % | $ | 491,991 | 100 | % | ||||||||||
|
* | The sum of the individual percentages does not equal the total due to rounding. |
16
Nine Months Ended | Nine Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue | Y/Y% | Revenue | Revenue | ||||||||||||||||
Converters
|
$ | 931,088 | 47 | % | 29 | % | $ | 723,923 | 50 | % | ||||||||||
Amplifiers / Radio frequency
|
502,532 | 25 | % | 34 | % | 374,667 | 26 | % | ||||||||||||
Other analog
|
247,581 | 12 | % | 77 | % | 140,244 | 10 | % | ||||||||||||
|
||||||||||||||||||||
Subtotal analog signal processing
|
1,681,201 | 84 | % | 36 | % | 1,238,834 | 86 | % | ||||||||||||
Power management & reference
|
139,089 | 7 | % | 69 | % | 82,288 | 6 | % | ||||||||||||
|
||||||||||||||||||||
Total analog products
|
$ | 1,820,290 | 91 | % | 38 | % | $ | 1,321,122 | 92 | % | ||||||||||
|
||||||||||||||||||||
Digital signal processing
|
171,223 | 9 | % | 40 | % | 122,186 | 8 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 1,991,513 | 100 | % | 38 | % | $ | 1,443,308 | 100 | % | ||||||||||
|
Three Months Ended | Nine Months Ended | |||||||||||||||
Region | July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | ||||||||||||
United States
|
$ | 129,933 | $ | 94,326 | $ | 375,256 | $ | 298,713 | ||||||||
Rest of North and South America
|
40,189 | 23,961 | 108,052 | 63,714 | ||||||||||||
Europe
|
186,035 | 120,899 | 504,031 | 369,499 | ||||||||||||
Japan
|
109,530 | 91,480 | 325,751 | 235,749 | ||||||||||||
China
|
132,119 | 85,317 | 347,642 | 274,374 | ||||||||||||
Rest of Asia
|
122,484 | 76,008 | 330,781 | 201,259 | ||||||||||||
|
||||||||||||||||
Total revenue
|
$ | 720,290 | $ | 491,991 | $ | 1,991,513 | $ | 1,443,308 | ||||||||
|
17
Fair Value measurement at | ||||||||||||
Reporting Date using: | ||||||||||||
Portion of | ||||||||||||
Carrying | Quoted Prices | Significant | ||||||||||
Value | in Active | Other | ||||||||||
Measured at | Markets for | Observable | ||||||||||
Fair Value | Identical Assets | Inputs | ||||||||||
July 31, 2010 | (Level 1) | (Level 2) | ||||||||||
Assets
|
||||||||||||
Cash Equivalents:
|
||||||||||||
Available for sale:
|
||||||||||||
Institutional money market funds
|
$ | 922,927 | $ | 922,927 | $ | — | ||||||
Corporate obligations
|
44,970 | — | 44,970 | |||||||||
Short—term investments:
|
||||||||||||
Available for sale:
|
||||||||||||
Corporate obligations (1)
|
1,404,886 | — | 1,404,886 | |||||||||
Floating rate notes, issued at par
|
110,000 | — | 110,000 | |||||||||
Other Assets:
|
||||||||||||
Other investments
|
1,140 | 1,140 | — | |||||||||
Deferred
compensation investments
|
7,998 | 7,998 | — | |||||||||
Interest
rate swap agreements
|
22,002 | — | 22,002 | |||||||||
|
||||||||||||
Total assets measured at fair value
|
$ | 2,513,923 | $ | 932,065 | $ | 1,581,858 | ||||||
|
||||||||||||
|
||||||||||||
Liabilities
|
||||||||||||
Forward foreign currency exchange contracts (2)
|
$ | 3,039 | $ | — | $ | 3,039 | ||||||
Long-term debt
|
395,756 | — | 395,756 | |||||||||
|
||||||||||||
|
||||||||||||
Total liabilities measured at fair value
|
$ | 398,795 | $ | — | $ | 398,795 | ||||||
|
(1) | The amortized cost of the Company’s investments classified as available for sale as of July 31, 2010 and October 31, 2009 was $1,451.1 million and $1,137.9 million, respectively. At July 31, 2010, $1,387.4 million of these investments had maturities of less than one year and $17.5 million had maturities of greater than one year. | |
(2) | The Company has a master netting arrangement by counterparty with respect to derivative contracts. Contracts in an asset position of $2.3 million have been netted against contracts in a liability position in the condensed consolidated balance sheets. |
18
Three Months Ended | Nine Months Ended | |||||||||||||||||||||||
July 31, 2010 | July 31, 2010 | |||||||||||||||||||||||
Gain/(Loss) on | Gain/(Loss) | Net Income | Gain/(Loss) | Gain/(Loss) | Net Income | |||||||||||||||||||
Income Statement Classification | Swaps | on Note | Effect | on Swaps | on Note | Effect | ||||||||||||||||||
Other income
|
$ | 12,372 | $ | (12,372 | ) | $ | — | $ | 15,893 | $ | (15,893 | ) | $ | — |
19
Balance Sheet Location | Fair Value | |||||
Interest rate swap agreements
|
Other Assets | $ | 22,002 | |||
Forward foreign currency exchange contracts
|
Accrued liabilities | $ | 2,627 |
Three Months | Nine Months | |||||||
Ended | Ended | |||||||
July 31, 2010 | July 31, 2010 | |||||||
Loss recognized
in OCI on derivative, net of tax of $356 and $1,513, respectively
|
$ | 1,816 | $ | 9,058 | ||||
Loss reclassified from OCI into income, net of tax of $668 and $460, respectively
|
$ | 3,404 | $ | 1,880 |
20
Nine Months | ||||
Ended | ||||
July 31, 2010 | ||||
Balance at beginning of period
|
$ | 250,881 | ||
Foreign currency translation adjustment
|
(47 | ) | ||
|
||||
Balance at end of period
|
$ | 250,834 | ||
|
July 31, 2010 | October 31, 2009 | |||||||||||||||
Gross | Gross | |||||||||||||||
Carrying | Accumulated | Carrying | Accumulated | |||||||||||||
Amount | Amortization | Amount | Amortization | |||||||||||||
Technology-based
|
$ | 39,801 | $ | 38,512 | $ | 39,924 | $ | 34,213 | ||||||||
Customer relationships
|
4,906 | 4,304 | 5,181 | 4,037 | ||||||||||||
|
||||||||||||||||
Total
|
$ | 44,707 | $ | 42,816 | $ | 45,105 | $ | 38,250 | ||||||||
|
Fiscal | Amortization | |||
Year | Expense | |||
Remainder of 2010
|
$ | 628 | ||
2011
|
$ | 1,263 |
21
Three Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Service cost
|
$ | 1,413 | $ | 1,617 | ||||
Interest cost
|
2,252 | 2,430 | ||||||
Expected return on plan assets
|
(2,598 | ) | (2,731 | ) | ||||
Amortization of prior service cost
|
— | 1 | ||||||
Amortization of initial net asset
|
(6 | ) | (10 | ) | ||||
Amortization of net gain
|
(20 | ) | (132 | ) | ||||
|
||||||||
Net periodic pension cost
|
$ | 1,041 | $ | 1,175 | ||||
|
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Service cost
|
$ | 4,398 | $ | 4,699 | ||||
Interest cost
|
7,117 | 7,008 | ||||||
Expected return on plan assets
|
(8,219 | ) | (7,870 | ) | ||||
Amortization of prior service cost
|
— | 3 | ||||||
Amortization of initial net asset
|
(20 | ) | (29 | ) | ||||
Amortization of net gain
|
(69 | ) | (381 | ) | ||||
|
||||||||
Net periodic pension cost
|
$ | 3,207 | $ | 3,430 | ||||
|
22
23
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Total revenue
|
$ | — | $ | 10,332 | ||||
Cost of sales
|
— | 10,847 | ||||||
Operating expenses
|
— | 15 | ||||||
Gain on sale of discontinued operations
|
1,316 | — | ||||||
|
||||||||
Gain (loss) before income taxes
|
1,316 | (530 | ) | |||||
Provision for (benefit from) income taxes
|
457 | (894 | ) | |||||
|
||||||||
Total income from discontinued operations, net of tax
|
$ | 859 | $ | 364 | ||||
|
July 31, 2010 | October 31, 2009 | |||||||
Refundable foreign withholding tax
|
$ | — | $ | 62,037 | ||||
|
||||||||
Total assets reclassified to non-current assets of discontinued operations
|
$ | — | $ | 62,037 | ||||
|
24
25
26
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
Revenue
|
$ | 720,290 | $ | 491,991 | $ | 1,991,513 | $ | 1,443,308 | ||||||||
Gross margin %
|
66.7 | % | 54.1 | % | 64.4 | % | 55.2 | % | ||||||||
Income from continuing operations,
net of tax
|
$ | 199,491 | $ | 65,460 | $ | 486,231 | $ | 141,799 | ||||||||
Income from continuing operations,
net of tax
as a % of revenue
|
27.7 | % | 13.3 | % | 24.4 | % | 9.8 | % | ||||||||
Diluted EPS from continuing operations
|
$ | 0.65 | $ | 0.22 | $ | 1.59 | $ | 0.49 | ||||||||
Diluted EPS
|
$ | 0.65 | $ | 0.22 | $ | 1.59 | $ | 0.49 |
27
Three Months Ended | Three Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue | Y/Y% | Revenue | Revenue* | ||||||||||||||||
Industrial
|
$ | 340,505 | 47 | % | 69 | % | $ | 201,900 | 41 | % | ||||||||||
Automotive
|
83,539 | 12 | % | 62 | % | 51,497 | 10 | % | ||||||||||||
Consumer
|
128,616 | 18 | % | 23 | % | 104,432 | 21 | % | ||||||||||||
Communications
|
153,657 | 21 | % | 24 | % | 123,550 | 25 | % | ||||||||||||
Computer
|
13,973 | 2 | % | 32 | % | 10,612 | 2 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 720,290 | 100 | % | 46 | % | $ | 491,991 | 100 | % | ||||||||||
|
* | The sum of the individual percentages does not equal the total due to rounding. |
Nine Months Ended | Nine Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue* | Y/Y% | Revenue | Revenue | ||||||||||||||||
Industrial
|
$ | 918,419 | 46 | % | 46 | % | $ | 629,676 | 44 | % | ||||||||||
Automotive
|
239,943 | 12 | % | 82 | % | 131,510 | 9 | % | ||||||||||||
Consumer
|
366,546 | 18 | % | 40 | % | 262,576 | 18 | % | ||||||||||||
Communications
|
425,496 | 21 | % | 11 | % | 383,713 | 27 | % | ||||||||||||
Computer
|
41,109 | 2 | % | 15 | % | 35,833 | 2 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 1,991,513 | 100 | % | 38 | % | $ | 1,443,308 | 100 | % | ||||||||||
|
* | The sum of the individual percentages does not equal the total due to rounding. |
28
Three Months Ended | Three Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue* | Y/Y% | Revenue | Revenue | ||||||||||||||||
Converters
|
$ | 334,288 | 46 | % | 34 | % | $ | 249,162 | 51 | % | ||||||||||
Amplifiers / Radio frequency
|
184,397 | 26 | % | 53 | % | 120,288 | 24 | % | ||||||||||||
Other analog
|
87,651 | 12 | % | 60 | % | 54,757 | 11 | % | ||||||||||||
|
||||||||||||||||||||
Subtotal analog signal processing
|
606,336 | 84 | % | 43 | % | 424,207 | 86 | % | ||||||||||||
Power management & reference
|
53,413 | 7 | % | 91 | % | 27,987 | 6 | % | ||||||||||||
|
||||||||||||||||||||
Total analog products
|
$ | 659,749 | 92 | % | 46 | % | $ | 452,194 | 92 | % | ||||||||||
|
||||||||||||||||||||
Digital signal processing
|
60,541 | 8 | % | 52 | % | 39,797 | 8 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 720,290 | 100 | % | 46 | % | $ | 491,991 | 100 | % | ||||||||||
|
* | The sum of the individual percentages does not equal the total due to rounding. |
Nine Months Ended | Nine Months Ended | |||||||||||||||||||
July 31, 2010 | August 1, 2009 | |||||||||||||||||||
% of | % of | |||||||||||||||||||
Revenue | Revenue | Y/Y% | Revenue | Revenue | ||||||||||||||||
Converters
|
$ | 931,088 | 47 | % | 29 | % | $ | 723,923 | 50 | % | ||||||||||
Amplifiers / Radio frequency
|
502,532 | 25 | % | 34 | % | 374,667 | 26 | % | ||||||||||||
Other analog
|
247,581 | 12 | % | 77 | % | 140,244 | 10 | % | ||||||||||||
|
||||||||||||||||||||
Subtotal analog signal processing
|
1,681,201 | 84 | % | 36 | % | 1,238,834 | 86 | % | ||||||||||||
Power management & reference
|
139,089 | 7 | % | 69 | % | 82,288 | 6 | % | ||||||||||||
|
||||||||||||||||||||
Total analog products
|
$ | 1,820,290 | 91 | % | 38 | % | $ | 1,321,122 | 92 | % | ||||||||||
|
||||||||||||||||||||
Digital signal processing
|
171,223 | 9 | % | 40 | % | 122,186 | 8 | % | ||||||||||||
|
||||||||||||||||||||
Total revenue
|
$ | 1,991,513 | 100 | % | 38 | % | $ | 1,443,308 | 100 | % | ||||||||||
|
29
Three Months Ended | Nine Months Ended | |||||||||||||||
Region | July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | ||||||||||||
United States
|
$ | 129,933 | $ | 94,326 | $ | 375,256 | $ | 298,713 | ||||||||
Rest of North and
South America
|
40,189 | 23,961 | 108,052 | 63,714 | ||||||||||||
Europe
|
186,035 | 120,899 | 504,031 | 369,499 | ||||||||||||
Japan
|
109,530 | 91,480 | 325,751 | 235,749 | ||||||||||||
China
|
132,119 | 85,317 | 347,642 | 274,374 | ||||||||||||
Rest of Asia
|
122,484 | 76,008 | 330,781 | 201,259 | ||||||||||||
|
||||||||||||||||
Total revenue
|
$ | 720,290 | $ | 491,991 | $ | 1,991,513 | $ | 1,443,308 | ||||||||
|
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
Gross margin
|
$ | 480,202 | $ | 266,229 | $ | 1,283,193 | $ | 796,783 | ||||||||
Gross margin %
|
66.7 | % | 54.1 | % | 64.4 | % | 55.2 | % |
30
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31 , 2010 | August 1, 2009 | |||||||||||||
R&D expenses
|
$ | 126,987 | $ | 107,578 | $ | 364,165 | $ | 336,854 | ||||||||
R&D expenses as a % of revenue
|
17.6 | % | 21.9 | % | 18.3 | % | 23.3 | % |
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
SMG&A expenses
|
$ | 102,070 | $ | 79,706 | $ | 288,211 | $ | 249,828 | ||||||||
SMG&A expenses as a % of revenue
|
14.2 | % | 16.2 | % | 14.5 | % | 17.3 | % |
31
32
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
Operating income from continuing operations
|
$ | 251,145 | $ | 78,945 | $ | 614,334 | $ | 156,445 | ||||||||
Operating income from continuing operations as
a % of
revenue
|
34.9 | % | 16.0 | % | 30.8 | % | 10.8 | % |
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
Interest expense
|
$ | 2,614 | $ | 1,368 | $ | 7,720 | $ | 1,368 | ||||||||
Interest income
|
(3,206 | ) | (2,558 | ) | (7,411 | ) | (13,881 | ) | ||||||||
Other expense (income), net
|
416 | 108 | 417 | (1,260 | ) | |||||||||||
|
||||||||||||||||
Total nonoperating (income) expense
|
$ | (176 | ) | $ | (1,082 | ) | $ | 726 | $ | (13,773 | ) | |||||
|
33
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
Provision for income taxes
|
$ | 51,830 | $ | 14,567 | $ | 127,377 | $ | 28,419 | ||||||||
Effective income tax rate
|
20.6 | % | 18.2 | % | 20.8 | % | 16.7 | % |
Three Months Ended | Nine Months Ended | |||||||||||||||
July 31, 2010 | August 1, 2009 | July 31, 2010 | August 1, 2009 | |||||||||||||
Income from continuing operations, net of tax
|
$ | 199,491 | $ | 65,460 | $ | 486,231 | $ | 141,799 | ||||||||
Income from continuing operations, net of tax as
a % of revenue
|
27.7 | % | 13.3 | % | 24.4 | % | 9.8 | % | ||||||||
Diluted EPS from continuing operations
|
$ | 0.65 | $ | 0.22 | $ | 1.59 | $ | 0.49 |
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Income from discontinued operations, net of tax
|
$ | — | $ | 364 | ||||
Gain on sale of discontinued operations, net of tax
|
859 | — | ||||||
|
||||||||
Total income from discontinued operations, net of tax
|
$ | 859 | $ | 364 | ||||
|
||||||||
Diluted EPS from discontinued operations
|
$ | 0.00 | $ | 0.00 | ||||
|
34
Nine Months Ended | ||||||||
July 31, 2010 | August 1, 2009 | |||||||
Net cash provided by operations
|
$ | 716,899 | $ | 269,470 | ||||
Net cash provided by operations as a %
of revenue
|
36.0 | % | 18.7 | % |
July 31, 2010 | October 31, 2009 | |||||||
Accounts receivable
|
$ | 357,479 | $ | 301,036 | ||||
Days sales outstanding
|
45 | 48 | ||||||
|
||||||||
Inventory
|
$ | 265,266 | $ | 253,161 | ||||
Days cost of sales in inventory
|
101 | 92 |
35
36
37
38
39
• | the effects of adverse economic conditions in the United States and international markets; | ||
• | changes in customer demand for our products and for end products that incorporate our products; | ||
• | the effectiveness of our efforts to refocus our operations, including our ability to reduce our cost structure in both the short term and over a longer duration; | ||
• | the timing of new product announcements or introductions by us, our customers or our competitors; | ||
• | competitive pricing pressures; | ||
• | fluctuations in manufacturing yields, adequate availability of wafers and other raw materials, and manufacturing, assembly and test capacity; | ||
• | the ability of our third party suppliers, subcontractors and manufactures to supply us with sufficient quantities of products or components; | ||
• | any significant decline in our backlog; | ||
• | the timing, delay or cancellation of significant customer orders and our ability to manage inventory; | ||
• | our ability to hire, retain and motivate adequate numbers of engineers and other qualified employees to meet the demands of our customers; | ||
• | changes in geographic, product or customer mix; | ||
• | our ability to utilize our manufacturing facilities at efficient levels; | ||
• | potential significant litigation-related costs; | ||
• | the difficulties inherent in forecasting future operating expense levels, including with respect to costs associated with labor, utilities, transportation and raw materials; | ||
• | the costs related to compliance with increasing worldwide environmental regulations; | ||
• | changes in our effective tax rates in the United States, Ireland or worldwide; and | ||
• | the effects of public health emergencies, natural disasters, widespread travel disruptions, security risks, terrorist activities, international conflicts and other events beyond our control. |
40
41
42
43
• | difficulty integrating acquired technologies, operations and personnel with our existing businesses; | ||
• | diversion of management attention in connection with both negotiating the acquisitions and integrating the assets; | ||
• | strain on managerial and operational resources as management tries to oversee larger operations; | ||
• | the future funding requirements for acquired companies, which may be significant; | ||
• | potential loss of key employees; | ||
• | exposure to unforeseen liabilities of acquired companies; and | ||
• | increased risk of costly and time-consuming litigation. |
44
• | seek additional financing in the debt or equity markets; | ||
• | refinance or restructure all or a portion of our indebtedness, including the notes; | ||
• | sell selected assets; | ||
• | reduce or delay planned capital expenditures; or | ||
• | reduce or delay planned operating expenditures. |
45
• | crises in global credit, debt and financial markets; | ||
• | actual or anticipated fluctuations in our revenue and operating results; | ||
• | changes in financial estimates by securities analysts or our failure to perform in line with those estimates or our published guidance; | ||
• | changes in market valuations of other semiconductor companies; | ||
• | announcements by us or our competitors of significant new products, technical innovations, acquisitions or dispositions, litigation or capital commitments; | ||
• | departures of key personnel; | ||
• | actual or perceived noncompliance with corporate responsibility or ethics standards by us or any of our employees, officers or directors; and | ||
• | negative media publicity targeting us or our competitors. |
46
Approximate Dollar | ||||||||||||||||
Total Number of | Value of Shares that | |||||||||||||||
Shares Purchased as | May Yet Be | |||||||||||||||
Total Number of | Part of Publicly | Purchased Under | ||||||||||||||
Shares Purchased | Average Price | Announced Plans or | the Plans or | |||||||||||||
Period | (a) | Paid Per Share (b) | Programs (c) | Programs | ||||||||||||
May 2, 2010 through
May 29, 2010
|
304 | $ | 28.35 | — | $ | 91,614,067 | ||||||||||
May 30, 2010
through June 26,
2010
|
25,750 | $ | 28.91 | 25,750 | $ | 90,869,540 | ||||||||||
June 27, 2010
through July 31,
2010
|
110,749 | $ | 29.87 | 110,559 | $ | 87,567,549 | ||||||||||
|
||||||||||||||||
Total
|
136,803 | $ | 29.68 | 136,309 | $ | 87,567,549 | ||||||||||
|
(a) | Includes 494 shares surrendered to us to satisfy the exercise price of options, and to satisfy employee tax obligations upon vesting of restricted stock, granted to them under our equity compensation plans. | |
(b) | The average stock price for each share surrendered to us to satisfy the exercise price of options, and to satisfy employee tax obligations upon vesting of restricted stock, granted to them under our equity compensation plans. | |
(c) | Repurchased pursuant to the stock repurchase program publicly announced on August 12, 2004. On June 6, 2007, our Board of Directors authorized the repurchase by us of an additional $1 billion of our common stock, increasing the total amount of our common stock we are authorized to repurchase under the program to $4 billion. Under the repurchase program, we may repurchase outstanding shares of our common stock from time to time in the open market and through privately negotiated transactions. Unless terminated earlier by resolution of our Board of Directors, the repurchase program will expire when we have repurchased all shares authorized for repurchase under the repurchase program. |
47
48
ANALOG DEVICES, INC.
|
||||
Date: August 17, 2010 | By: | /s/ Jerald G. Fishman | ||
Jerald G. Fishman | ||||
President and
Chief Executive Officer
(Principal Executive Officer) |
||||
Date: August 17, 2010 | By: | /s/ David A. Zinsner | ||
David A. Zinsner | ||||
Vice President, Finance
and
Chief Financial Officer (Principal Financial Officer) |
49
Exhibit No. | Description | |||
31.1 |
Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities
Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002 (Chief Executive Officer).
|
|||
|
||||
31.2 |
Certification Pursuant to Rule 13a-14(a) and 15d-14(a) of the Securities
Exchange Act, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act
of 2002 (Chief Financial Officer).
|
|||
|
||||
32.1 |
Certification Pursuant to 18 U.S.C. Section 1350 (Chief Executive Officer).
|
|||
|
||||
32.2 |
Certification Pursuant to 18 U.S.C. Section 1350 (Chief Financial Officer).
|
|||
|
||||
101.INS |
XBRL Instance Document.
|
|||
|
||||
101.SCH |
XBRL Schema Document.
|
|||
|
||||
101.CAL |
XBRL Calculation Linkbase Document.
|
|||
|
||||
101.LAB |
XBRL Labels Linkbase Document.
|
|||
|
||||
101.PRE |
XBRL Presentation Linkbase Document.
|
|||
|
||||
101.DEF |
XBRL Definition Linkbase Document.
|
Attached as Exhibit 101 to this report are the following formatted in XBRL (Extensible Business Reporting Language): (i) Condensed Consolidated Statements of Income for the three months and nine months ended July 31, 2010 and August 1, 2009, (ii) Condensed Consolidated Balance Sheets at July 31, 2010 and October 31, 2009, (iii) Condensed Consolidated Statements of Cash Flows for the nine months ended July 31, 2010 and August 1, 2009 and (iv) Notes to Condensed Consolidated Financial Statements. | ||
In accordance with Rule 406T of Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q is deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act, is deemed not filed for purposes of Section 18 of the Exchange Act, and otherwise is not subject to liability under these sections. |
50
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|---|---|---|
VINCENT ROCHE, 64 , Chief Executive Officer and Chair of the Board of Directors Mr. Roche was elected as Chair of our Board of Directors in March 2022. Mr. Roche has served as our President since 2012, and was appointed CEO and elected as a director in May 2013. Mr. Roche began his career with us in 1988 and has served in key positions spanning corporate leadership, worldwide sales, strategic marketing, business development, and product management over his more than 30-year tenure. Mr. Roche was recognized by Forbes in 2019 as one of America’s Most Innovative Leaders while also being a recipient of the 2021 SFI St. Patrick’s Day Science Medal for his contributions in support of the ecosystems in Ireland. | |||
PROFESSIONAL EXPERIENCE AND BACKGROUND I n January 2024, Dr. Wee co-founded DevAI, an early-stage, VC-backed startup focused on helping businesses and developers build AI solutions. Dr. Wee serves as DevAI’s Chief Executive Officer. Previously. Dr. Wee served as a Vice President at Google, a multinational technology company, from April 2022 to March 2023. From November 2019 to August 2021, Dr. Wee served as Senior Vice President and General Manager of DevNet and CX Ecosystem Success at Cisco Systems Inc., a technology company. Dr. Wee founded and led DevNet, Cisco’s developer program, beginning in October 2013. Dr. Wee began working at Cisco in April 2011, and held leadership roles including Senior Vice President & Chief Technology Officer of DevNet from October 2018 to November 2019, Vice President & Chief Technology Officer of DevNet from October 2013 to October 2018, Vice President & Chief Technology Officer of Networked Experiences from October 2012 to October 2013, and Vice President & Chief Technology and Experience Officer of Cisco’s Collaboration Technology Group from April 2011 to October 2012. Previously, Dr. Wee had a 15-year career at Hewlett Packard Enterprise Company, a technology company, where she held a number of technical and leadership roles, including Vice President and General Manager of the HP Experience Software Business and Lab Director at HP Labs. Dr. Wee is an IEEE fellow and serves on the visiting committee of the MIT Electrical Engineering and Computer Science department. KEY QUALIFICATIONS AND EXPERTISE Dr. Wee brings to our Board of Directors extensive experience in information technology, emerging technologies, application development, AI, and an established track record of driving software innovation at global technology companies. OTHER PUBLIC COMPANY BOARDS Current: None Past 5 Years: None | |||
PROFESSIONAL EXPERIENCE AND BACKGROUND Dr. Glimcher has served as a Professor of Microbiology and Immunology at Harvard Medical School since May 2017, the Richard and Susan Smith Professor of Medicine at Harvard Medical School and Dana-Farber Cancer Institute since October 2016, an Attending Physician, Department of Cancer Immunology and Virology at Dana-Farber Cancer Institute since October 2016, and President Emerita of the Dana-Farber Cancer Institute since October 2024. Dr. Glimcher served as Chief Executive Officer of the Dana-Farber Cancer Institute from September 2016 to October 2024. In addition to a number of senior leadership roles held at both Harvard Medical School and Harvard School of Public Health from 1984 to 2011 and from October 2016 to present, she also served as the Stephen and Suzanne Weiss Dean and Professor of Medicine of Weill Cornell Medicine and Provost for Medical Affairs of Cornell University from January 2012 to August 2016. She is a member of the board of trustees at the Dana-Farber Cancer Institute and a member of the U.S. National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society. KEY QUALIFICATIONS AND EXPERTISE Dr. Glimcher brings to our Board of Directors scientific and public health expertise, as well as diversity of technical skills and experience managing large, complex organizations, and as a physician, scientist, and professor. OTHER PUBLIC COMPANY BOARDS Current: None Past 5 Years: Waters Corporation (until 2020); GlaxoSmithKline plc (until 2022) | |||
PROFESSIONAL EXPERIENCE AND BACKGROUND Ms. Golz is a retired Partner of Ernst & Young LLP (EY), a public accounting firm, where she was Global Vice Chair, Japan from 2016 to 2017 and previously Global Vice Chair, Professional Practice from 2010 to 2016. Ms. Golz also served on EY’s Global Risk Management Executive Committee, which was charged with risk management across EY’s global network, from 2008 to 2016. Ms. Golz currently serves as Senior Advisor to The Boston Consulting Group’s Audit and Risk Committee, a role she has held since August 2017, and as a Principal for K.M. Golz Associates, LLC, a consulting services company, since August 2017. Ms. Golz also sits on the board of trustees of the University of Illinois Foundation. Ms. Golz is a NACD Board Leadership Fellow and also earned the NACD CERT Certificate in Cybersecurity Oversight from Carnegie Mellon University. KEY QUALIFICATIONS AND EXPERTISE Ms. Golz brings to our Board of Directors accounting and audit expertise, deep enterprise risk management experience, and extensive experience helping large organizations successfully navigate the complexities of international trade and regulation. OTHER PUBLIC COMPANY BOARDS Current: Aspen Technology, Inc.; iRobot Corporation Past 5 Years: None | |||
PROFESSIONAL EXPERIENCE AND BACKGROUND Since September 2022, Dr. Frank has been the Executive Chair of Gradient Technologies, Inc., a security technologies startup, focused on identity and access management, and was co-founder and CEO of Cloud Parity Inc., a voice of the customer startup, from January 2014 through August 2016. From May 2009 to October 2013, Dr. Frank held the position of Vice President, Macintosh Hardware Systems Engineering at Apple Inc., a company that designs, manufactures, and markets electronic devices. Prior to his tenure at Apple, Dr. Frank served as Corporate Vice President, Research and Development, of Broadcom Corp. Dr. Frank was founding CEO of Epigram, Inc., a developer of integrated circuits and software for home networking, which Broadcom acquired in 1999, and was a Distinguished Engineer at Sun Microsystems, Inc. Since 2000, Dr. Frank has been a Trustee of Carnegie Mellon University and served as vice-chair from 2015 through 2021. Dr. Frank has served on the board of directors of Metallica’s All Within My Hands Foundation since July 2017, where he also served as Executive Director (pro bono) from July 2017 through December 2021. He is a member of the National Academy of Engineering and a Fellow of the IEEE. KEY QUALIFICATIONS AND EXPERTISE Dr. Frank brings to our Board of Directors substantial experience in the design, manufacture, sale, and marketing of semiconductors for a broad set of markets, including many of the markets we service and brings extensive executive leadership experience. Dr. Frank also brings significant cybersecurity experience to our Board of Directors. OTHER PUBLIC COMPANY BOARDS Current: SiTime Corp.; Rocket Lab USA, Inc.; Blaize Holdings, Inc. Past 5 Years: Amesite, Inc. (until 2020); Marvell Technology, Inc. (until 2023) | |||
PROFESSIONAL EXPERIENCE AND BACKGROUND Ms. Wainer has served as Executive Vice President, Rapid and Molecular Diagnostics at Abbott Laboratories (Abbott), a medical devices and health care company, since 2019. During her nearly 22 years at Abbott, Ms. Wainer has served in roles of increasing responsibility including as President, Abbott Molecular Diagnostics, from 2015 to 2019, President, Abbott Animal Health, from 2011 to 2014, and Divisional Vice President/General Manager, Abbott Renal Care, from 2009 to 2011. Ms. Wainer serves as a member of the Board of Trustees of the Goodman Theatre. KEY QUALIFICATIONS AND EXPERTISE Ms. Wainer brings to our Board of Directors deep expertise leading innovative businesses in the diagnostics and pharmaceutical industries, including significant experience with complex commercial and manufacturing operations and continuous improvement. OTHER PUBLIC COMPANY BOARDS Current: None Past 5 Years: None |
Name and
Principal Position |
Fiscal
Year |
Salary
($) |
Bonus
($)
|
|
Stock
Awards ($) |
Option
Awards ($) |
Non-Equity
Incentive Plan Compensation ($) |
All Other
Compensation ($) |
Total
($) |
|||||||||||||||||||||||||||||||||||||||||
Vincent Roche
Chief Executive Officer & Chair of the Board of Directors
|
2024
|
$ | 1,137,692 | $ | — | $ | 19,999,288 | $ | — | $ | 628,707 | $ | 670,928 | $ | 22,436,615 | |||||||||||||||||||||||||||||||||||
2023
|
$ | 1,128,846 | $ | — | $ | 19,997,672 | $ | — | $ | 4,071,924 | $ | 345,193 | $ | 25,543,635 | ||||||||||||||||||||||||||||||||||||
2022
|
$ | 1,075,000 | $ | — | $ | 15,000,172 | $ | — | $ | 5,560,731 | $ | 462,392 | $ | 22,098,295 | ||||||||||||||||||||||||||||||||||||
Richard C. Puccio, Jr.
Executive Vice President & Chief Financial Officer
|
2024
|
$ | 476,731 | $ | 500,000 | $ | 15,498,994 | $ | — | $ | 119,505 | $ | 575,072 | $ | 17,170,302 | |||||||||||||||||||||||||||||||||||
Gregory Bryant
Former Executive Vice President & President of Business Units
|
2024
|
$ | 711,058 | $ | — | $ | 8,000,003 | $ | — | $ | 294,707 | $ | 75,285 | $ | 9,081,053 | |||||||||||||||||||||||||||||||||||
2023
|
$ | 735,577 | $ | — | $ | 7,999,186 | $ | — | $ | 2,025,866 | $ | 77,646 | $ | 10,838,275 | ||||||||||||||||||||||||||||||||||||
2022
|
$ | 475,962 | $ | — | $ | 31,500,396 |
|
$ | — | $ | 2,141,827 | $ | 49,277 | $ | 34,167,462 | |||||||||||||||||||||||||||||||||||
Vivek Jain
Executive Vice President of Global Operations & Technology
|
2024
|
$ | 616,250 | $ | — | $ | 5,250,121 | $ | — | $ | 212,844 | $ | 65,000 | $ | 6,144,215 | |||||||||||||||||||||||||||||||||||
2023
|
$ | 637,500 | $ | — | $ | 5,249,301 | $ | — | $ | 1,424,075 | $ | 52,200 | $ | 7,363,076 | ||||||||||||||||||||||||||||||||||||
2022
|
$ | 579,212 | $ | — | $ | 5,000,181 | $ | — | $ | 1,936,907 | $ | 40,738 | $ | 7,557,038 | ||||||||||||||||||||||||||||||||||||
Anelise Sacks
Former Executive Vice President & Chief Customer Officer
|
2024
|
$ | 592,548 | $ | — | $ | 5,000,002 | $ | — | $ | 204,657 | $ | 55,551 | $ | 5,852,758 | |||||||||||||||||||||||||||||||||||
2023
|
$ | 600,962 | $ | — | $ | 4,999,551 | $ | — | $ | 1,367,801 | $ | 50,719 | $ | 7,019,033 | ||||||||||||||||||||||||||||||||||||
2022
|
$ | 512,500 | $ | — | $ | 4,700,101 | $ | — | $ | 1,735,039 | $ | 205,102 | $ | 7,152,742 | ||||||||||||||||||||||||||||||||||||
James Mollica
Former Interim Chief Financial Officer
|
2024
|
$ | 326,411 | $ | — | $ | 904,950 | $ | — | $ | 47,549 | $ | 26,113 | $ | 1,305,023 |
Customers
Customer name | Ticker |
---|---|
NACCO Industries, Inc. | NC |
Science Applications International Corporation | SAIC |
Texas Instruments Incorporated | TXN |
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|---|---|---|
STATA RAY | - | 176,946 | 652,221 |
ROCHE VINCENT | - | 142,996 | 43,515 |
Cotter Martin | - | 69,172 | 0 |
Bryant Gregory M | - | 59,093 | 0 |
Puccio Richard C Jr | - | 49,916 | 0 |
Jain Vivek | - | 48,227 | 0 |
Mahendra-Rajah Prashanth | - | 47,576 | 0 |
SICCHITANO KENTON J | - | 27,489 | 0 |
Sondel Michael | - | 18,847 | 0 |
Sondel Michael | - | 8,614 | 0 |
CHAMPY JAMES | - | 7,886 | 38,316 |
Jain Vivek | - | 5,815 | 0 |
ROCHE VINCENT | - | 5,713 | 55,000 |
Frank Edward H. | - | 3,753 | 3,000 |
Sacks Anelise Angelino | - | 2,715 | 0 |
Henry Peter B. | - | 314 | 0 |
DOLUCA TUNC | - | 0 | 59,657 |